Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607880 · ClinicalTrials.gov registry record · Phase 2
Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00607880: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00607880 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00607880, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
RATIONALE: Giving chemotherapy drugs through an implanted port reduces the need for multiple needle sticks. It is not yet known whether one type of port is more effective than another in reducing infections and other side effects associated with long-term port use. PURPOSE: This randomized clinical trial is comparing two types of ports in patients with cancer receiving intravenous chemotherapy.
Interventions
- PROCEDURE vascular access device placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2004-06 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00607880
The ClinicalTrials.gov registry entry for NCT00607880 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vascular access device placement is the first listed.
NCT00607880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00607880 about?
NCT00607880 is a clinical study titled "Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy". RATIONALE: Giving chemotherapy drugs through an implanted port reduces the need for multiple needle sticks. It is not yet known whether one type of port is more effective than another in reducing infections and other side effects associated with long-term port use. PURPOSE: This randomized clinical...
What is the current status of trial NCT00607880?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2004-06. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00607880?
The interventions under investigation include: vascular access device placement (PROCEDURE).
Who is sponsoring clinical trial NCT00607880?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.